You just read:

European Hematology Association: Multicenter Open-label Phase 2 Study of ibrutinib in Chronic Graft Versus Host Disease (cGVHD) After Failure of Corticosteroids

News provided by

European Hematology Association

Jun 24, 2017, 02:30 ET